Tirzepatide: The Promising New Drug for Obesity and Weight Loss

Tirzepatide, a drug approved to treat type 2 diabetes, has shown promising results in helping people with diabetes who were overweight or had obesity lose up to 16% of their body weight over nearly 17 months. The drug targets the digestive and chemical pathways that underlie obesity, suppressing appetite and blunting cravings for food. If approved for weight loss, tirzepatide could become the most effective drug to date in an arsenal of medications that are transforming the treatment of obesity, which affects more than 4 in 10 American adults and is linked to dozens of diseases that can lead to disability or death.